Bank of New York Mellon Corp

Holdings History for REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Investment type: Debt / NOTE 1.750% 2/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Dec 2023		-0%	$0	0	-200,000	-100%		Q4 2023
30 Sep 2023	0%	0%	$162,366	200,000	0		81.18%	Q3 2023
30 Jun 2023	0%	0%	$212,272	200,000	0		106.14%	Q2 2023
31 Mar 2023	0%	+0%	$246,480	200,000	+100,000	+100%	123.24%	Q1 2023
31 Dec 2022	0%	-0%	$100,250	100,000	-200,000	-67%	100.25%	Q4 2022
30 Sep 2022	0%	+0%	$314,000	300,000	+300,000	NEW	104.67%	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.